课题基金 / 基金详情

SYNTHESIS AND BIOLOGICAL EVALUATION/ANTIHIV NUCLEOSIDES

SYNTHESIS AND BIOLOGICAL EVALUATION/ANTIHIV NUCLEOSIDES
合成和生物学评价/抗HIV核苷
批准号:
6362302
负责人:
Chung K Chu
金额:
$24.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-01-01 至 2002-02-28

项目摘要

项目成果

Chung K Chu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract): Despite significant advances in the treatment of HIV infection, there are a number of unresolved issues in AIDS chemotherapy, including viral resistance, viral reservoir, salvage therapy and potential elimination of the virus. In order to solve all these problems, the critical need in the future will be the discovery of more potent and selective new anti-HIV regimens with different patterns of resistance than approved drugs. This proposal is a continuation of ongoing drug discovery efforts in the area of antiviral nucleosides at the University of Georgia and the Emory University/VA Medical Center. The investigators propose to explore the chemistry and virology of the following classes of mainly L-nucleosides: (1) oxaselenolane nucleosides; (2) fluorinated L-D4N; (3) 2-substituted L-carbocyclic nucleosides; (4) L-apionucleosides; (5) L-oxetanocin analogs; (6) cyclobutane carbocyclic L-nucleosides; (7) conformationally restricted endo-cyclopropropylnucleosides; (8) homo- cyclopropylcarbocyclic nucleosides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nucleoside & cidofovir analogs as pox virus antiviral
  • 批准号:
    6631226
  • 项目类别:
  • 资助金额:
    $10.95万
  • 财政年份:
    2002
  • 负责人:
    Chung K Chu
  • 依托单位:
Nucleoside & cidofovir analogs as pox virus antiviral
  • 批准号:
    6482450
  • 项目类别:
  • 资助金额:
    $10.95万
  • 财政年份:
    2001
  • 负责人:
    Chung K Chu
  • 依托单位:
Nucleoside & cidofovir analogs as pox virus antiviral
  • 批准号:
    6347077
  • 项目类别:
  • 资助金额:
    $10.95万
  • 财政年份:
    2000
  • 负责人:
    Chung K Chu
  • 依托单位:
ASYMMETRIC SYNTHESIS OF L-NUCLEOSIDES AS ANTI-HBV AGENTS
  • 批准号:
    6149782
  • 项目类别:
  • 资助金额:
    $26.87万
  • 财政年份:
    1993
  • 负责人:
    Chung K Chu
  • 依托单位:
海外基金